Drug Type Enzyme |
Synonyms PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), Pancrelipase controlled-release, Pertzye + [2] |
Target- |
Action- |
Mechanism Enzyme replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (17 May 2012), |
RegulationFast Track (United States) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Exocrine Pancreatic Insufficiency | United States | 17 May 2012 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic carcinoma non-resectable | Phase 2 | United States | 01 Dec 2016 | |
Cystic Fibrosis | Discovery | United States | 01 Jan 2007 | |
Steatorrhea | Discovery | United States | 01 Jan 2007 |